Lysosomal acid lipase in mesenchymal stem cell stimulation of tumor growth and metastasis

Ting Zhao, Cong Yan, Hong Du

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Bone marrow mesenchymal stem cells (MSCs) are an important participant in the tumor microenvironment, in which they promote tumor growth and progression. Here we report for the first time that depletion of lysosomal acid lipase (LAL) in MSCs impairs their abilities to stimulate tumor growth and metastasis both in allogeneic and syngeneic mouse models. Reduced cell viability was observed in LAL-deficient (lal-/-) MSCs, which was a result of both increased apoptosis and decreased proliferation due to cell cycle arrest. The synthesis and secretion of cytokines and chemokines that are known to mediate MSCs' tumor-stimulating and immunosuppressive effects, i.e., IL-6, MCP-1 and IL-10, were down-regulated in lal-/- MSCs. When tumor cells were treated with the conditioned medium from lal-/- MSCs, decreased proliferation was observed, accompanied by reduced activation of oncogenic intracellular signaling molecules in tumor cells. Co-injection of lal-/- MSCs and B16 melanoma cells into wild type mice not only induced CD8+ cytotoxic T cells, but also decreased accumulation of tumor-promoting Ly6G+CD11b+ myeloid-derived suppressor cells (MDSCs), which may synergistically contribute to the impairment of tumor progression. Furthermore, lal-/- MSCs showed impaired differentiation towards tumor-associated fibroblasts. In addition, MDSCs facilitated MSC proliferation, which was mediated by MDSCsecreted cytokines and chemokines. Our results indicate that LAL plays a critical role in regulating MSCs' ability to stimulate tumor growth and metastasis, which provides a mechanistic basis for targeting LAL in MSCs to reduce the risk of cancer metastasis.

Original languageEnglish (US)
Pages (from-to)61121-61135
Number of pages15
JournalOncotarget
Volume7
Issue number38
DOIs
StatePublished - 2016

Fingerprint

Sterol Esterase
Mesenchymal Stromal Cells
Neoplasm Metastasis
Growth
Neoplasms
Chemokines
Cell Proliferation
Cytokines
Experimental Melanomas
Tumor Microenvironment
Immunosuppressive Agents
Conditioned Culture Medium
Cell Cycle Checkpoints
Interleukin-10
Interleukin-6
Cell Survival
Bone Marrow

Keywords

  • Lysosomal acid lipase
  • Mesenchymal stem cell
  • Myeloid-derived suppressor cells
  • Tumor growth and metastasis

ASJC Scopus subject areas

  • Oncology

Cite this

Lysosomal acid lipase in mesenchymal stem cell stimulation of tumor growth and metastasis. / Zhao, Ting; Yan, Cong; Du, Hong.

In: Oncotarget, Vol. 7, No. 38, 2016, p. 61121-61135.

Research output: Contribution to journalArticle

@article{443f4d89398a4058a774e8fe3a8a1cb6,
title = "Lysosomal acid lipase in mesenchymal stem cell stimulation of tumor growth and metastasis",
abstract = "Bone marrow mesenchymal stem cells (MSCs) are an important participant in the tumor microenvironment, in which they promote tumor growth and progression. Here we report for the first time that depletion of lysosomal acid lipase (LAL) in MSCs impairs their abilities to stimulate tumor growth and metastasis both in allogeneic and syngeneic mouse models. Reduced cell viability was observed in LAL-deficient (lal-/-) MSCs, which was a result of both increased apoptosis and decreased proliferation due to cell cycle arrest. The synthesis and secretion of cytokines and chemokines that are known to mediate MSCs' tumor-stimulating and immunosuppressive effects, i.e., IL-6, MCP-1 and IL-10, were down-regulated in lal-/- MSCs. When tumor cells were treated with the conditioned medium from lal-/- MSCs, decreased proliferation was observed, accompanied by reduced activation of oncogenic intracellular signaling molecules in tumor cells. Co-injection of lal-/- MSCs and B16 melanoma cells into wild type mice not only induced CD8+ cytotoxic T cells, but also decreased accumulation of tumor-promoting Ly6G+CD11b+ myeloid-derived suppressor cells (MDSCs), which may synergistically contribute to the impairment of tumor progression. Furthermore, lal-/- MSCs showed impaired differentiation towards tumor-associated fibroblasts. In addition, MDSCs facilitated MSC proliferation, which was mediated by MDSCsecreted cytokines and chemokines. Our results indicate that LAL plays a critical role in regulating MSCs' ability to stimulate tumor growth and metastasis, which provides a mechanistic basis for targeting LAL in MSCs to reduce the risk of cancer metastasis.",
keywords = "Lysosomal acid lipase, Mesenchymal stem cell, Myeloid-derived suppressor cells, Tumor growth and metastasis",
author = "Ting Zhao and Cong Yan and Hong Du",
year = "2016",
doi = "10.18632/oncotarget.11244",
language = "English (US)",
volume = "7",
pages = "61121--61135",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "38",

}

TY - JOUR

T1 - Lysosomal acid lipase in mesenchymal stem cell stimulation of tumor growth and metastasis

AU - Zhao, Ting

AU - Yan, Cong

AU - Du, Hong

PY - 2016

Y1 - 2016

N2 - Bone marrow mesenchymal stem cells (MSCs) are an important participant in the tumor microenvironment, in which they promote tumor growth and progression. Here we report for the first time that depletion of lysosomal acid lipase (LAL) in MSCs impairs their abilities to stimulate tumor growth and metastasis both in allogeneic and syngeneic mouse models. Reduced cell viability was observed in LAL-deficient (lal-/-) MSCs, which was a result of both increased apoptosis and decreased proliferation due to cell cycle arrest. The synthesis and secretion of cytokines and chemokines that are known to mediate MSCs' tumor-stimulating and immunosuppressive effects, i.e., IL-6, MCP-1 and IL-10, were down-regulated in lal-/- MSCs. When tumor cells were treated with the conditioned medium from lal-/- MSCs, decreased proliferation was observed, accompanied by reduced activation of oncogenic intracellular signaling molecules in tumor cells. Co-injection of lal-/- MSCs and B16 melanoma cells into wild type mice not only induced CD8+ cytotoxic T cells, but also decreased accumulation of tumor-promoting Ly6G+CD11b+ myeloid-derived suppressor cells (MDSCs), which may synergistically contribute to the impairment of tumor progression. Furthermore, lal-/- MSCs showed impaired differentiation towards tumor-associated fibroblasts. In addition, MDSCs facilitated MSC proliferation, which was mediated by MDSCsecreted cytokines and chemokines. Our results indicate that LAL plays a critical role in regulating MSCs' ability to stimulate tumor growth and metastasis, which provides a mechanistic basis for targeting LAL in MSCs to reduce the risk of cancer metastasis.

AB - Bone marrow mesenchymal stem cells (MSCs) are an important participant in the tumor microenvironment, in which they promote tumor growth and progression. Here we report for the first time that depletion of lysosomal acid lipase (LAL) in MSCs impairs their abilities to stimulate tumor growth and metastasis both in allogeneic and syngeneic mouse models. Reduced cell viability was observed in LAL-deficient (lal-/-) MSCs, which was a result of both increased apoptosis and decreased proliferation due to cell cycle arrest. The synthesis and secretion of cytokines and chemokines that are known to mediate MSCs' tumor-stimulating and immunosuppressive effects, i.e., IL-6, MCP-1 and IL-10, were down-regulated in lal-/- MSCs. When tumor cells were treated with the conditioned medium from lal-/- MSCs, decreased proliferation was observed, accompanied by reduced activation of oncogenic intracellular signaling molecules in tumor cells. Co-injection of lal-/- MSCs and B16 melanoma cells into wild type mice not only induced CD8+ cytotoxic T cells, but also decreased accumulation of tumor-promoting Ly6G+CD11b+ myeloid-derived suppressor cells (MDSCs), which may synergistically contribute to the impairment of tumor progression. Furthermore, lal-/- MSCs showed impaired differentiation towards tumor-associated fibroblasts. In addition, MDSCs facilitated MSC proliferation, which was mediated by MDSCsecreted cytokines and chemokines. Our results indicate that LAL plays a critical role in regulating MSCs' ability to stimulate tumor growth and metastasis, which provides a mechanistic basis for targeting LAL in MSCs to reduce the risk of cancer metastasis.

KW - Lysosomal acid lipase

KW - Mesenchymal stem cell

KW - Myeloid-derived suppressor cells

KW - Tumor growth and metastasis

UR - http://www.scopus.com/inward/record.url?scp=84992478759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992478759&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.11244

DO - 10.18632/oncotarget.11244

M3 - Article

C2 - 27531897

AN - SCOPUS:84992478759

VL - 7

SP - 61121

EP - 61135

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 38

ER -